Daily Stock List
San Gold Corp. (SGR.TO)
Today we are reporting on San Gold Corp. (SGR.TO), here at the QualityStocks Daily Newsletter.
Based in Winnipeg, Manitoba, San Gold Corp. is a gold producer, explorer, and developer. The Company owns and operates the Hinge, 007, and Rice Lake mines near Bissett, Manitoba, approximately 235 kilometers northeast of Winnipeg. San Gold employs more than 400 people. The Company's shares trade on the Toronto Stock Exchange and on the OTCQX International under the symbol "SGRCF".
Mining operations are situated in the Rice Lake Greenstone Belt, in Bissett. The Rice Lake Project has a permitted, modern gold mill currently processing ore at a capacity of 2,500 tons per day, modern surface infrastructure including a licensed tailings management facility, and is connected to the Province of Manitoba power grid system. The Rice Lake mine has produced 1.5 million ounces of gold since 1931.
Ore is currently undergoing mining along two active underground mining trends. The Rice Lake mine is along the first trend within the Rice Lake gold belt to be put into commercial production. A second mining trend is the Shoreline Basalt mining unit. It was identified in late 2010 as part of San Gold's intensive exploration program. Operations in the Shoreline Basalt mining unit are focusing on two main operating areas, the Hinge and 007 deposits.
Last week, San Gold announced an updated mineral resource and mineral reserve estimate, 2012 production results with guidance for 2013 and 2014 and an exploration update for their 100 percent owned Rice Lake Mining Complex. Highlights include Proven and Probable mineral reserves of 253,000 ounces. This represents an increase of 21 percent from March 31, 2012 (an increase of 75 percent after accounting for mined ounces), and Measured and Indicated mineral resources of 655,000 ounces, an increase of 17 percent from March 31, 2012 (an increase of 32 percent after accounting for mined ounces).
Highlights also include the highest ever production in 2012 of 86,506 ounces of gold, an increase of 17 percent over 2011. Milling capacity was notably increased during the year to 2,500 tons per day from 2,000 tons. The Company has experienced continued exploration success along the depth extension of the 007 zone that returned 12.6 g/t gold over 6.0 meters and 15.5 g/t gold over 11.1 meters.
Concerning the 2013 development outlook, the goal of the development program, for this year and beyond, is to increase mine production to match the current mill capacity. Development will take place within the Property in four main areas: on 26 Level, 16 Level, A-Shaft of the Rice Lake mine, and within other active mining areas of the 007, Hinge, Cohiba and L13 deposits.
San Gold Corp. (SGR.TO), closed Thursday's trading session at $0.365, even for the day, on 4,839,833 volume. The stock's 52-week low/high is $0.35/$1.78.
Talon International, Inc. (TALN)
OTCEquity, VIP Penny Stocks, OtcWizard, PennyStockSpy, EpicVIP Group, Epic Stock Picks, Penny Stock Rumble, Stock Twiter, and Simply Best Penny Stocks reported earlier on Talon International, Inc. (TALN), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets' OTCQB, Talon International, Inc. is an international supplier of apparel fasteners, trim, and interlining products. They supply these products to manufacturers of fashion apparel, specialty retailers, brand licensees, mass merchandisers and major retailers. Talon International has offices and facilities in the United States (headquarters in Los Angeles), the UK, Hong Kong, China, Taiwan, India, and Bangladesh.
Talon manufactures and distributes zippers and other fasteners under their Talon® brand. This brand has a reputation as the original American zipper invented in 1893. The Company also designs, manufactures, engineers, and distributes apparel trim products and specialty waistbands under their trademark names, Talon, Tag-It, and TekFit. These are to major apparel brands and manufacturers including Wal-Mart, Kohl's, J.C. Penney, Victoria's Secret, Tom Tailor, Abercrombie and Fitch, Polo Ralph Lauren, Fat Face, Phillips-Van Heusen, Reebok, and Juicy Couture.
Talon International has sold the Tekfit© technology under such brands as Polo Ralph Lauren, Roundtree & Yorke, Jack Nicklaus and Bobby Jones Golf, Eddie Bauer and Levi's Dockers. Previously more than 50 million Tekfit© waistbands were used by Levi Strauss in their Dockers pants. Today, Tekfit© waistbands are being incorporated into quality sports and casual apparel by major retailers such as Dillard's, HMX and Saks 5th Avenue.
Their TekFit division delivers cutting-edge product innovation to the apparel industry. TekFit has exclusive rights to advanced fabric technologies, which facilitate the addition of mechanical stretch into most standard fabrics.
In October 2012, Talon International reported reaching a two-year agreement with Fat Face Group Ltd. to supply them all of their apparel Trim and Zipper products. Fat Face Group is a premier U.K. based retailer. They specialize in the design and sale of active lifestyle clothing and related accessories.
In addition, in October, Talon announced that because of their fast growing apparel accessory business the Company has relocated and expanded their operations within the U.K. Talon's EU operations have experienced major growth in the past year adding numerous industry leading retailers and brands to their customer list, including Burberry, Ben Sherman, Next and the Fat Face Group. Talon's new European offices are in Buckinghamshire, U.K.
Talon International, Inc. (TALN), closed Thursday's trading session at $0.05, up 25.00%, on 4,200 volume with 1 trade. The average volume for the last 60 days is 19,835 and the stock's 52-week low/high is $0.02/$0.19.
PEDEVCO Corp. (PEDO)
We are highlighting PEDEVCO Corp. (PEDO), here at the QualityStocks Daily Newsletter.
PEDEVCO Corp., d/b/a Pacific Energy Development (PEDO) is an energy company that engages in the acquisition and development of strategic, high growth energy projects, including shale oil and gas assets, in the U.S. and Pacific Rim countries. Members of the Company's team have developed and commercialized some of the industry's most profitable and successful energy ventures. PEDEVCO has their headquarters in Danville, California, and an office in Beijing, China. The Company's shares trade on the OTCBB.
PEDEVCO's producing assets include their Niobrara asset located in the DJ Basin in Colorado, the Eagle Ford asset in McMullen County, Texas, and the North Sugar Valley Field located in Matagorda County, Texas. They subsequently plan to pursue highly prospective shale oil and gas opportunities in Pacific Rim countries.
Concerning the Niobrara asset, PEDEVCO holds 31 percent Working Interest (WI) in the 9,500-plus acres in the Indian Peaks Area. First well, FFT2H, was successfully drilled and fracked, and is currently producing. Concerning the Eagle Ford Asset, PEDEVCO and their strategic partner MIE jointly hold 8 percent WI in the 1,651 acres in the Leighton Field Area. Three wells are currently producing.
In addition, the Company holds a Joint Venture (JV) interest in Rare Earth Ovonic Metal Hydride JV Co. Ltd., a privately held China-based rare earth metal production company located in Inner Mongolia. Since 2004, Rare Earth Ovanic has been in commercial production of mischmetal-based metal hydride powders.
This week, PEDEVCO announced that their second horizontal well, the Waves 1H well, located in Weld County, Colorado, tested at an initial production rate of 528 bopd and 360 mcfgpd (588 boepd) from the Niobrara "B" Bench target zone. Their JV partner, Condor Energy Technology LLC, operates the well. Condor spudded the Waves 1H well on November 19, 2012; they drilled to 11,114 feet measured depth (6,200 true vertical foot depth) in eight days. The 4,339-foot lateral section was completed in 18 stages on February 1, 2013.
Mr. Frank C. Ingriselli, PEDEVCO President and CEO commented, "We are pleased to be able to execute on our 2013 development program in the Niobrara formation, and are encouraged that the knowledge we gained from drilling and completing our initial FFT2H well in the Niobrara formation is proving beneficial to us as we seek to drive down our drilling and completion costs, optimize our completion operations, and maximize production and resource recovery."
PEDEVCO Corp. (PEDO), closed Thursday's trading session at $2.00, up 21.21%, on 33,055 volume with 11 trades. The average volume for the last 60 days is 1,762 and the stock's 52-week low/high is $0.2809/$5.00.
Fission Energy Corp. (FIS.V)
Stockhouse and Streetwise Reports reported earlier on Fission Energy Corp. (FIS.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Fission Energy Corp. is a resource company specializing in the strategic acquisition, exploration and development of uranium properties. The Company has properties in Saskatchewan's Athabasca Basin, Quebec, the Hornby Basin of Nunavut, Namibia and the Macusani District of Peru. Fission Energy's shares trade on the TSX Venture Exchange and on the OTCQX International under the trading symbol "FSSIF". The Company is based in Kelowna, British Columbia.
Fission Energy's main exploration focus is Saskatchewan's Athabasca Basin. The Basin is the home of the richest uranium mines in the world. Moreover, the Dieter Lake deposit, located in Quebec, is a significant uranium property with a large tonnage, low grade, NI 43-101 compliant Inferred resource. The majority of Fission's exploration properties in these two regions were acquired by staking in 2003-2004.
The Company is actively exploring at two core projects in the Athabasca Basin. One is their flagship Waterbury Lake project. The second is their emerging Patterson Lake South project (PLS). The 31,039 hectare PLS project is a 50-50 Joint Venture held by Fission Energy and Alpha Minerals, Inc (AMW.V). Fission Energy is the Operator. PLS is accessible by road, with primary access from all-weather Highway 955. This highway runs north to the former Cluff Lake mine, (>60M lbs of U3O8 produced), and passes through the nearby UEX-Areva Shea Creek discoveries located 50km to the north, currently under active exploration and development.
Last week, Fission Energy and their Joint Venture partner Alpha Minerals announced the results of the first two holes of the Winter 2013 exploration program at the Patterson Lake South (PLS) property. The 2nd step-out hole at PLS hit 37m of continuous mineralization including a total of 4.35m off-scale radioactivity.
Today, Fission Energy announced that they staked three additional claims on the southern border of their Patterson Lake South (PLS) project. The newly acquired ground is referred to as the Clearwater West Project. It is owned 100 percent by Fission. The claims are 7km south of the mineralized boulder field and 12.5km south of the mineralized holes on the PLS property and consist of a total area of 11,535.39ha.
Fission Energy Corp. (FIS.V), closed Thursday's trading session at $0.89, up 4.88%, on 1,455,882 volume. The stock's 52-week low/high is $0.34/$0.90.
Labrador Iron Mines Holdings Ltd. (LIM.TO)
Vantage Wire and Super Stock Picker reported previously on Labrador Iron Mines Holdings Ltd. (LIM.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the Toronto Stock Exchange, Labrador Iron Mines Holdings Ltd. is Canada's newest iron ore producer. The Company has a portfolio of direct shipping (DSO) iron ore operations and projects located in the prolific Labrador Trough. Currently, Labrador Iron Mines is the only independently owned Canadian iron ore producer listed on the Toronto Stock Exchange. The Company has their corporate headquarters in Toronto, Ontario. In addition, they have offices in Schefferville, Quebec, and in St. John's, Labrador City, and Goose Bay Newfoundland and Labrador.
Labrador Iron Mines' mine operations involve the extraction of iron ore by developing open pit mines, starting with the James Mine. The James Mine is connected by a direct rail link to the Port of Sept-Îles, Québec. The project also benefits from established infrastructure including the town, airport, and hydropower and railway service.
Starting with the James Mine and leading to the development of the expanding Houston flagship project, the Company has a plan to increase production towards 5 million tonnes annually from a portfolio of 20 iron ore deposits in Labrador and Quebec, all within 50 kilometers of the town of Schefferville.
Initial production started at the James Mine in June 2011, with the sale of 386,000 dry tonnes of iron ore recorded in the first start-up year. The first full production season began in April 2012; Labrador Iron Mines sold ten shipments totaling approximately 1.6 million dry tonnes of iron ore. The tenth shipment sold at the end of November and contained 103,000 dry tonnes of iron ore.
This week, Labrador Iron Mines announced that they would be releasing their December 2012 Third Quarter results before the market opens on Friday, February 15, 2013. The Company's financial statements and Management's Discussion and Analysis will be available on the Company's website and filed on SEDAR. Members of their senior management team will host a conference call and webcast on Friday, February 15, 2013 at 11:00 am (ET) to discuss the results.
Labrador Iron Mines Holdings Ltd. (LIM.TO), closed Thursday's trading session at $0.80, down 4.76%, on 879,290 volume. The stock's 52-week low/high is $0.56/$6.14.
Oragenics, Inc. (OGEN)
We are highlighting Oragenics, Inc. (OGEN), here at the QualityStocks Daily Newsletter.
Based in Tampa, Florida, Oragenics, Inc. is a biopharmaceutical company whose shares trade on the OTC Bulletin Board. The Company is primarily focusing on oral probiotics products and novel antibiotics for humans and companion pets. Oragenics has established an exclusive global channel collaboration for lantibiotics, a novel class of broad-spectrum antibiotics, with Intrexon Corp., Inc., a synthetic biology company. In addition, Oragenics develops, markets and sells proprietary probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora in more than 13 countries worldwide.
The Company's collaboration with Intrexon will allow Oragenics access to Intrexon's proprietary technologies with the idea of speeding up the development of much needed new antibiotics that will work against resistant strains of bacteria. Founded in 1996 by Dr. Jeffrey Hillman and Dr. Robert Zahradnik, Oragenics is concentrating on internally developing or in-licensing technologies and partnering with industry leaders to create novel therapies and diagnostic products.
Oragenics' focus on the probiotic area will be to grow sales through an array of channels. These include internet sales and the professional channel (dentists and hygienists) and via private label and bulk sales of their patented ProBiora3® blend. ProBiora3® is Oragenics' proprietary blend of probiotics specifically designed for oral care. The Company's intention is to seek opportunities to expand their health claims for these products through a range of clinical studies. Additionally, Oragenics is looking at novel and convenient new delivery systems for their probiotics that they plan to commercialize in the near future.
This week, Oragenics announced their ProBiora3® tablets have successfully completed an independent third party review of their Cosmetic Product Safety Report. ProBiora3® is now formulated as a cosmetic mouthwash tablet for use in the European Union (EU). All Oragenics' independent distributors can now distribute the ProBiora3® tablets in the EU under a Cosmetic designation.
In addition, this week, Oragenics announced that their Exclusive Channel Collaboration (ECC) with Intrexon produced an exponential increase in the fermentation titer of the target compound MU1140 and the discovery of a promising new purification process for this product. The Company relates that this demonstrates significant progress toward the commercial production of their lead lantibiotic, MU1140. Furthermore, it delivers an important step in validating the lantibiotics platform targeting infectious diseases.
Oragenics and Intrexon have been working together through the ECC to produce a pipeline of new lantibiotics that have been shown to be active against essentially all Gram-positive pathogens. These include vancomycin-resistant enterococci (VRE), Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and multi-drug resistant strains of Mycobacterium tuberculosis.
Oragenics, Inc. (OGEN), closed Thursday's trading session at $4.02, up 14.86%, on 56,900 volume with 75 trades. The average volume for the last 60 days is 12,088 and the stock's 52-week low/high is $1.75/$3.60.
Porter Bancorp, Inc. (PBIB)
UltimatePennyStock reported recently on Porter Bancorp, Inc. (PBIB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Listed on the NASDAQ Global Market, Porter Bancorp, Inc. is the parent company of PBI Bank, Inc. The Bank has 18 full-service banking offices in Kentucky. PBI Bank is a full service bank headquartered in Louisville, Kentucky. They have many banking centers located across Central Kentucky. The Bank opened for business in 1902.
PBI Bank underwent restructuring in 1988 with the merger of three banks. Historically, the Bank conducted their banking business through separate community banks under the common control of J. Chester Porter, their Chairman, and Maria L. Bouvette, their President and CEO. In 2004, PBI Bank started to streamline operations through consolidating their subsidiary banks under common control into a single bank.
They completed this reorganization on December 31, 2005 - they acquired the interests of other shareholders in their three partially owned subsidiary bank holding companies in exchange for shares of convertible, non-voting common stock, cash and indebtedness. On December 31, 2005, they also renamed their consolidated subsidiary PBI Bank, creating a single brand name for all of their banking operations.
At the end of January, Porter Bancorp reported unaudited results for the fourth quarter and year ended December 31, 2012.
They reported a net loss to common shareholders of $7.0 million, or ($0.59) per diluted share, for the fourth quarter of 2012. This is in comparison to a net loss to common shareholders of $54.5 million, or ($4.64) per diluted share, for the fourth quarter of 2011.
Net loss to common shareholders for the year ended December 31, 2012, was $33.4 million, or ($2.85) per diluted common share. This is in comparison to a net loss to common shareholders of $105.2 million, or ($8.98) per diluted share, for the year ended December 31, 2011. The loss for the year ended December 31, 2011, includes a non-recurring 100 percent goodwill impairment charge of $23.8 million recorded in the second quarter of 2011, and the establishment of a 100 percent deferred tax valuation allowance of $31.7 million in the fourth quarter of 2011.
Porter Bancorp's financial performance continues to be negatively affected by the Bank's high level of nonperforming loans and other real estate owned. The Company's Management and the Board of Directors are evaluating appropriate strategies for increasing the Company's capital to meet the capital requirements of their Consent Order. These include, among other things, a possible public offering or private placement of common stock to new and existing shareholders.
Major goals of Porter Bancorp for this year are asset quality remediation, capital restoration, and lowering the risk profile of the Company.
Porter Bancorp, Inc. (PBIB), closed Thursday's trading session at $1.0001, up 6.39%, on 1,665 volume with 5 trades. The average volume for the last 60 days is 12,003 and the stock's 52-week low/high is $0.62/$2.68.
Green Automotive Co. (GACR)
Best Stock Picks, Pick Alerts, and Premiumstockpicks reported previously on Green Automotive Co. (GACR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Green Automotive Co. is a state-of-the-art niche vehicle design, engineering, manufacturing, and sales company whose shares trade on the OTCQB. The Company employs innovative zero and low emission technologies. In addition, they provide a comprehensive after sales program maximizing the lifetime value of clean transport solutions. Green Automotive recently acquired Liberty Electric Cars Ltd. in Europe. Green Automotive has their corporate headquarters in Newport Beach, California.
The Company has businesses that are active in three main market segments. These include - advanced vehicle technology development, engineering & design with a focus on zero and low emission solutions; manufacturing and customization of vehicles for niche markets with the potential to undergo conversion into low emission or electric vehicles, and after sales support programs for electric or low emission vehicles including parts, servicing and repair.
Green Automotive's two main divisions servicing these three segments are Liberty Electric Cars Ltd. and Newport Coachworks, Inc. Liberty Electric Cars designs and develops EV technologies for use in their converted vehicles and for sale to Original Equipment Manufacturers (OEMs) for incorporation into their production. Furthermore, they provide a complete aftermarket program for electric vehicle users to ensure the longevity of their vehicles.
Newport Coachworks specializes in building high quality shuttle buses, running on an assortment of energy sources from petrol and diesel through to Compressed Natural Gas (CNG). In January, Green Automotive announced that Newport Coachworks received from Don Brown Bus Sales, Inc. a major increase to their original order. This supplementary order will result in Newport Coachworks increasing their production by six buses per month over the next two years. This additional order is for a mix of Limousine-type buses and shuttle buses. Don Brown Bus Sales is one of North America's leading bus distributors.
This week, Green Automotive announced that they signed a binding agreement to buy UK-based electric vehicle distributor Going Green Ltd. Going Green, doing business under the brand name "GoinGreen," has sold more than 1,400 of the highly successful G-Wiz electric vehicles. This makes them Europe's largest single retailer of electric vehicles, generating annual revenues in excess of $1 Million.
Green Automotive Co. (GACR), closed Thursday's trading session at $0.40, even for the day, on 26,700 volume with 5 trades. The average volume for the last 60 days is 7,444 and the stock's 52-week low/high is $0.15/$1.01.
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.118, up 7.27%, on 42,255 volume with 5 trades. The stock’s average daily volume over the past 60 days is 63,662, and its 52-week low/high is $0.0069/$0.13.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
Viscount Systems Awarded Contract to Secure Additional U.S. Government Facilities
Viscount Systems Receives Contract to Secure Four High Rise Towers
Viscount Systems Awarded Contract to Secure North Dakota Schools
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.321, up 6.61%, on 145,479 volume with 48 trades. The stock’s average daily volume over the past 60 days is 217,256, and its 52-week low/high is $0.161/$0.65.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results in Metabolic Liver Disease Program
International Stem Cell Corporation Announces Positive Results From In Vivo Animal Study of Parkinson's Disease
International Stem Cell Corporation Announces Positive Animal Efficacy Results in Liver Disease Program
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.1899, off by 0.16%, on 165,384 volume with 127 trades. The stock’s average daily volume over the past 60 days is 179,399, and its 52-week low/high is $0.17/$0.30.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium's Excellagen® Awarded American Podiatric Medical Association Seal of Approval, Company Also Announces Addition of a Regional Distributor for Excellagen
Cardium Announces Presentation at The 2013 Cell & Gene Therapy Forum
Cardium To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.014, off by 0.71%, on 621,700 volume with 19 trades. The stock’s average daily volume over the past 60 days is 756,821, and its 52-week low/high is $0.0013/$0.015.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
25 Acres of Giant King Grass Shipped by VIASPACE and Growing in St. Croix
VIASPACE Chairman and CEO Attend EUEC 2013, Giant King Grass Prominently Featured in Convention Exhibit Hall
VIASPACE Signs Project Agreement and Growing Giant King Grass in South Africa
The advent of stem cell technology is proving to be one of the most foundational developments in the history of modern medicine. Like the stem cell itself, this rapidly developing technology is showing a remarkable ability to transform itself, revealing new opportunities in a rising number of medical applications. Although some awareness of the ability of some cells to change into other cells has been known for a long time, it’s only been in the past several decades that researchers have begun to appreciate the range of capabilities that stem cells represent. The result has been an explosion of possibilities in our understanding and work with the human body.
Perhaps best known is the work being done in the field of regenerative medicine, using stem cells to replace or regenerate damaged human cells. Potential applications are wide spread, from the use of stem cells to help control diabetes, to the healing of damaged hearts, to dealing with the many diseases associated with nerve or brain cell damage.
In some cancers, such as certain leukemias and lymphomas, damaged stem cells that are no longer able to do their job can be removed and replaced with healthy stem cells. Stem cell transplants are becoming an increasingly important cancer therapy.
Stem cells are also being used in research. By using pluripotent stem cells to create various specific cell types, researchers can perform any number of complex medical experiments that would otherwise be difficult or even impossible to perform.
Today there is yet another field of growing interest: the use of stem cells for early drug testing, an area focused on by VistaGen Therapeutics. VistaGen has developed a way to use its proprietary human pluripotent stem cell technology to develop an advanced testing platform called Human Clinical Trials in a Test Tube™. It allows drug development companies to test the effects of new drug candidates on real heart and liver cells without having to wait for clinical trials. This represents a huge money-saving advantage, avoiding the expense involved in developing a drug only to have it fail due to heart or liver toxicity, a major problem in the industry. The goal of VistaGen is to use this technology to discover, rescue, and develop novel drug candidates for a wide range of diseases.
For additional information, visit www.VistaGen.com
India Globalization Capital has announced financial results for the third quarter ending Dec. 31, 2012.
“We are pleased to report profitability this quarter due to our considerable efforts to realign and focus our equipment, processes and people on the iron ore mining business, cut costs from unprofitable construction contracts and renegotiate or extinguish expense liabilities and debt,” said Ram Mukunda, CEO of India Globalization Capital. “Our revenues for the quarter rose dramatically to nearly $4 million, and we achieved earnings of $0.01 per share.”
The company’s total revenue was $3,933,906 for the three months ending Dec. 31; this is compared with $986,799 for the corresponding time period of 2011. This revenue increase resulted from a rise in trading activity as the company gears up for production in its mines. One revenue component of $802,746 was the result of closing out a construction contract that TBL, the company’s Indian subsidiary, was engaged in. In the next fiscal year beginning in April, TBL projects that revenue and margins will rise as iron ore prices are expected to trend up from increased infrastructure activity in China, India, the U.S., and other locations across the globe. It is the company’s current expectation to begin purchasing low-grade iron ore after the Chinese New Year and winter and to begin transporting it to plants for further beneficiation and sale to customers. IGC has four mines in Inner Mongolia and three beneficiation plants with more than $500 million in estimated reserves measured at $125 per ton.
During the three months that ended Dec. 31, IGC reported a GAAP net income of $310,892 and a GAAP EPS of $0.01 per share, as contrasted with a consolidated net loss of $1,901,375 and a GAAP EPS loss of $0.09 for the same three-month period of 2011. The substantial earnings shift is due to four factors: a significant cut in SG&A as the company aligns its resources for mining and trading; redeployment of construction equipment for mining; a marked decrease in high interest loans and liability; and a rise in iron ore trading revenue as well as revenue associated with the closure of a construction contract. As IGC beneficiates iron ore by converting low-grade iron ore to high-grade iron ore – in an environment where iron prices are trending higher – the arbitrage between low- and high-grade iron ore will increase and drive the company’s margins and earnings higher. IGC has put a great deal of energy into aligning its resources and integrating its mining business, and the company predicts that, based on current iron ore pricing trends, its next fiscal year will be profitable.
IGC’s selling, general, and administrative expenses for the period ending Dec. 31 were $153,789, as compared with $968,890 for the same period in 2011. The company has significantly cut employees and overheads and eliminated recurring contracts associated with construction activity.
IGC’s cash and cash equivalents, along with restricted cash, was around $2.1 million for the period ending Dec. 31. The company’s stockholders’ equity was around $15.6 million as of Dec. 31, as compared with around $15.8 million for the period ending March 31, 2012.
The company’s total reported assets were around $21.4 million as of Dec. 31, compared with around $25.3 million as of March 30, 2012.
“We are now filling orders from our Chinese customers through our trading operations,” said Mukunda. “We expect to increase this activity as we expand our suppliers beyond India and China. In the future, the lower margin trading business is expected to transition to higher margins as we supply high-grade iron ore from our beneficiation plants. As reported in Bloomberg, in September 2012 China approved $158 billion for infrastructure as part of a stimulus plan that is expected to boost the demand for commodities. Iron ore prices have started to recover from their lows of $86 per ton in September 2012 to around $125 per ton. We have about $500 million of iron ore deposits, four mine sites, and three beneficiation plants. Our short term strategy is three-pronged: 1) Start supplying high grade iron ore from our beneficiation plants; 2) Expand the supply chain for raw materials beyond India and China; and 3) Actively look at consolidating more mines in the Inner Mongolia region that can be accretive to the company.”
For more information, visit www.indiaglobalcap.com
Noble Roman’s, the Indianapolis-based franchisor of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, issued an update on the expansion of its take-n-bake (TBN) concept, which is available in grocery stores as well as in the stand-alone TNB franchise structure.
In the last three weeks alone, Noble Roman’s has entered into two new franchise agreements, bringing the total number of TNB units to 11, eight of which are currently under development or construction and are expected to open during the first half of 2013.
In the first six weeks of 2013, the company has expanded the number of grocery stores offering its TNB pizza to 1,445. Marketing efforts include attending grocery trade shows such as the National Grocers Association trade show in Las Vegas, held this week, where the company can raise awareness of its unique position in the pizza market.
“Take-n-bake is the fastest growing segment of the pizza industry,” Paul Mobley, chairman and CEO, Noble Roman’s stated in the press release. “And Noble Roman’s is at the forefront of this trend, methodically increasing our presence in grocery stores around the country and growing our stand-alone TNB franchises. We continue to grow our pipeline of franchise prospects for the stand-alone take-n-bake concept, and expect to have several others under development by mid-year.”
Mobley said that as Noble Roman’s approaches 1,500 grocery stores carrying its TNB product, the company anticipates steady growth to this grocery network in upcoming quarters, which ultimately results in additional revenue stream.
“With our recognized brand and our reputation for great taste and high quality, we are poised to grow our revenues and profitability due to the popularity of the TNB concept,” he concluded.
For more information, visit www.nobleromans.com
PureSafe Water Systems has entered into strategic agreements with Global Equipment Marketing Inc. (GEM) and Engineering Technologies Group Inc. (ETG) to enhance PureSafe’s ability to meet immediate and long-term market demand for the company’s mobile water purification systems. The agreement sent shares of PureSafe soaring 153% today on heavy volume.
“This is a significant milestone for PureSafe,” Adam Seltzer, managing director of Dominick and Dominick, investment advisor to PureSafe, stated in the press release. “It has enabled the company to engage two renowned firms that have significant experience and expertise on both the engineering side of the business, as well as the sales, marketing and distribution of equipment. This partnership is a major step forward and should allow PureSafe to expedite manufacturing in order to meet market demand. This relationship also gives PureSafe the ability to eventually roll-out its product worldwide without taking on the expenses of having direct sales, marketing, distribution and engineering costs ‘in house.’ We expect that this model will allow the company to maximize value using the expertise of GEM and ETG to enhance its water treatment technology and expedite distribution capabilities.”
GEM distributes large-scale production and process equipment throughout the world. By operating as PureSafe Water System Sales (PWSS), the company will tap into its existing dealer network to establish a global distribution network, adding new dealers and representatives as well as secure direct sales and alliances needed to distribute the PureSafe product.
ETG is a full-service engineering firm specializing in general equipment and process engineering, environmental services, and the design and supply of various engineered products. Per its arrangement with PureSafe, ETG will provide engineering services resulting in a more easily and efficiently manufactured PureSafe product. Additional product line expansion, enhancements, and developments will also originate here.
Leveraging the strengths of both partners, PureSafe plans to accelerate global sales, implement a value engineering program, and improve product manufacturing.
“The engineering review and value engineering program we are embarking on will create a product that will be more easily manufactured with the highest level of quality and reliability built-in,” Denis Roy, vice president of ETG stated. “This program will also be the foundation for an ever-expanding line of water filtration products to meet the needs of world markets.”
For more information visit www.puresafewatersystems.com
Today's Top 3
The QualityStocks Public Company Sponsor News